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ABSTRACT
A commercial reverse transcription (RT)-PCR amplification method was compared with culture for the
diagnosis of enterovirus meningitis. In total, 99 cerebrospinal fluid (CSF) specimens were examined with
the Enterovirus Consensus kit and shell vial culture. RT-PCR allowed the amplification of enterovirus
cDNA and its detection in a microtitre plate by hybridisation. Clinical information and CSF analysis
were used to resolve the discrepancy in results. The detection limit of the RT-PCR assay was determined
with the Third European Union Concerted Action Enterovirus Proficiency Panel. There were 34 true-
positive CSF specimens. Of these, RT-PCR detected 33 (sensitivity 97%), while culture detected 19
(sensitivity 54.5%). RT-PCR failed to detect one culture-positive specimen that contained inhibitors.
When samples from the Third European Union Concerted Action Enterovirus Proficiency Panel were
tested, the RT-PCR method gave identical results to those expected. The Enterovirus Consensus kit was
rapid and statistically more sensitive than culture (p < 0.01) for the detection of enteroviruses in CSF,
and may offer considerable benefits in the clinical management of patients with enterovirus meningitis.
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INTRODUCTION
Enteroviruses are important pathogens with a
wide range of clinical manifestations. Most infec-
tions are mild or asymptomatic, but enteroviruses
may also result in serious or even fatal disease [1].
They are the most commonly identified cause of
virus meningitis in the paediatric population,
accounting for 80–92% of all cases in which a
causative agent is identified [2].
Specific diagnosis of enterovirus meningitis has
many advantages in patient management [3].
Traditionally, enteroviruses have been detected
by isolation in cell culture, with their identity
established by neutralisation of infectivity with
serotype-specific antisera. Although virus isola-
tion has been regarded as the reference method
for detecting enterovirus infection, cell culture
procedures are poorly standardised, require mul-
tiple cell lines, and are labour-intensive and time-
consuming; also, many of the viruses in this
diverse group do not grow well in tissue culture
[4]. Recent developments in molecular detection
technology mean that diagnosis of enterovirus
infections is achieved increasingly by non-cul-
ture-based methods, particularly nucleic acid
amplification methods such as reverse transcrip-
tion (RT)-PCR [5]. Several clinical studies have
demonstrated the importance of the increased
sensitivity and rapid turn-around time of RT-PCR
and other molecular approaches for enterovirus
detection [6,7].
Unnecessary investigations and empirical ther-
apy with antibacterial and anti-herpes simplex
virus agents can be avoided by rapid and specific
diagnosis of enterovirus meningitis, thus redu-
cing the duration of hospital stay [8,9]. Since the
first report of the successful clinical application of
molecular methods to enterovirus detection [10],
many procedures have been described, including
‘in-house’ assays [11–15] and commercially
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available kits [16–19]. Various endpoint detection
or quantification systems, such as colourimetric
microwell hybridisation assays [14,16–20] and a
real-time RT-PCR method based on TaqMan
technology [21], have been described in order to
achieve the sensitivity required for optimal clin-
ical utility. The present study evaluated a new
commercial assay (Enterovirus Consensus kit) in
comparison with virus culture for the diagnosis of
enterovirus central nervous system infections in
children and adults. The sensitivity and specific-
ity were determined in relation to clinical infor-
mation and cerebrospinal fluid (CSF) analysis.
MATERIALS AND METHODS
Patients and CSF specimens
In total, 99 consecutive CSF specimens from 99 patients, aged
2–71 years, were collected in sterile containers and sent to the
Microbiology Department for diagnostic evaluation. The
patients were admitted between April 2001 and December
2002 to the University Hospital of Ioannina as a result of acute
neurological illness, with clinical signs that resulted in the
treating physician requesting a lumbar puncture. Clinical
information was obtained from the request form and from the
physician. None of the patients was immunosuppressed, and
none had been receiving antibiotics.
Quantitative and qualitative cytological CSF analysis, and
direct examination of CSF by Gram’s stain for bacteria, by acid-
fast stain for mycobacteria, and by India ink stain for
Cryptococcus, were performed systematically. Culture of CSF
on appropriate media (i.e., blood agar, MacConkey agar,
chocolate agar, Haemophilus isolation agar, Sabouraud’s dex-
trose agar, thioglyconate on broth and Lo¨wenstein-Jensen egg
medium) for bacteria and fungi was performed simulta-
neously.
CSF analysis for enterovirus isolation and genome detection
was performed immediately (during laboratory working
hours), or the CSF was stored at ) 80C and processed within
24 h.
Enterovirus cell culture
CSF was cultured directly on two different cell lines (buffalo
green monkey kidney and human embryonic rhabdomyosar-
coma cells) (Vircell, Granada, Spain) with the standard shell
vial culture procedure [22]. In brief, shell vials were inoculated
with 200 lL of CSF and centrifuged at 700 g for 45 min at room
temperature. After addition of maintenance medium (Eagle’s
minimum essential medium containing fetal bovine serum 2%
v ⁄v), the shell vials were incubated at 37C for 48 h. The
coverslips were removed from the vials and attached to a
microscope slide, which was then incubated with 25 lL of
monoclonal antibody (Vircell) directed against the VP1 en-
terovirus capsid protein for 30 min at 37C [23]. After washing,
each slide was incubated with 25 lL of fluorescein-labelled
anti-mouse immunoglobulin for 30 min at 37C. The presence
of typical fluorescent inclusions confirmed the presence of
virus.
RT-PCR assay
The Enterovirus Consensus kit (Argene Biosoft, Varilhes,
France) was used according to the manufacturer’s instructions,
with one exception, mentioned below.
Specimen preparation
Virus RNA was extracted from 140 lL of CSF with the
QIAamp Viral RNA Blood Mini kit (Qiagen, Valencia, CA,
USA) according to the manufacturer’s instructions. Elution
was performed with an RNase-free buffer; total virus RNA
was stored at ) 80C until required for RT-PCR.
Amplification
Detection of 64 serotypes (polioviruses 1–3, coxsackieviruses
A1–A22, A24 and B1–B6, echoviruses 1–9, 11–21, 24–27, 29–33,
and enteroviruses 68–71) was performed by a single ampli-
fication with the consensus stair primer system. The primers
(Penter-1 and -2) were selected from within the 5¢ non-coding
region of the enterovirus genome and were 85% identical to
known enterovirus RNA sequences, thereby allowing ampli-
fication of a sequence with a 3¢ mutation with good efficiency
[24,25]. A 10-lL aliquot of the extracted material was added
to 40 lL of a master mix prepared using buffers and enzymes
provided by the manufacturer. RT of target RNA and
amplification of cDNA was done in a single-tube reaction
following the amplification program described by the manu-
facturer. The RT-PCR was carried out in a PTC 200 therm-
ocycler (MJ Research, Reno, NV, USA). A positive control,
consisting of a plasmid with a coxsackie B4 virus sequence
provided by the manufacturer, was used as an amplification-
positive sample. The absence of inhibitors was demonstrated
by addition of this positive control (included in the inhibition
control pre-mix) to a duplicate sample after RNA extraction
and RT. The amplified cDNA products were analysed with
electrophoresis on agarose 2% w ⁄v gels in the presence of
ethidium bromide (final concentration in gel and buffer of
0.5 lg ⁄mL) and visualised by UV illumination. The size of the
amplified fragment, located in the non-coding conserved
portion of the enterovirus genome, was 425 bp. This step, not
included in the manufacturer’s recommendations, was pre-
liminary to the hybridisation detection step, and enabled
possible contamination or problems with the amplification
(e.g., a positive band with the negative control) to be
detected.
Detection
Following chemical denaturation, the single-stranded PCR
products obtained from samples and internal controls were
hybridised separately with two different biotinylated probes
and detected with a streptavidin–peroxidase system in a
microtitre plate. Results were scored as positive when the
optical density value at 450 ⁄ 650 nm was above a cut-off value
calculated for each serial assay according to the recommenda-
tions of the manufacturer.
The total time required for the Enterovirus Consensus kit
was c. 7 h, comprising 1 h for RNA extraction, 3 h for RT-PCR,
and 3 h for the detection step. To validate the assay, each
RT-PCR analysis included four types of control: (1) a positive
control of RNA extracted from poliovirus oral trivalent vaccine
(Sabin); (2) an inhibition control; (3) an amplification-negative
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control of sterile distilled water; and (4) a negative control for
detection, which was tested in duplicate during the detection
step.
External quality control
To determine the sensitivity and specificity of the enterovirus
detection method with different enterovirus serotypes, the
laboratory participated in the external quality assessment
programme established by themembers of the EuropeanUnion
(EU) Quality Concerted Action (QCCA) of Nucleic Acid
Amplification in Diagnostic Virology (University Medical
Centre, Utrecht, The Netherlands). The third enterovirus panel,
which was shipped by the EU-QCCA Working Party on
Enteroviruses, consisted of 13 coded samples: three samples of
a dilution series of echovirus 11 (25.2, 252 and 25 100 · 50% tis-
sue culture infective doses (TCID50) ⁄mL of the original virus
stock), three samples of a ten-fold dilution series of coxsackie-
virus A9 (4, 0.4 and 0.04 TCID50 ⁄mL), one sample of echovirus 6
(20 000 TCID50 ⁄mL), one sample of coxsackievirus B5 (317
TCID50 ⁄mL), one sample of enterovirus 71 (56 TCID50 ⁄mL), two
samples with no virus, and two samples containing the
‘Amorced Enterovirus RNA’ preparation (104 and 107 RNA
copies ⁄mL) (Table 1). Sampleswere testedblind, and the results
were compared with the expected results, based upon those
obtained by three reference laboratories, with a total of four
different molecular methods, before distribution of the panel.
Data interpretation
RT-PCR results were compared with those of virus culture. In
the case of discrepancies, the RT-PCR was repeated and
clinical information and the results of CSF analysis were
obtained. Patients were defined as having an enterovirus
central nervous system infection on the basis of the following
criteria: clinical evidence consistent with meningitis ⁄ enceph-
alitis (i.e., fever, headache, vomiting, nuchal rigidity, photo-
phobia, abdominal pain, irritability, seizures, alterations of
consciousness) and the absence of another detectable patho-
gen, and either (1) detection of an enterovirus genome in CSF
virus culture, or (2) positive CSF enterovirus culture without a
positive RT-PCR.
Sensitivity, specificity and positive and negative predictive
values were calculated. Statistical significance was calculated
with chi-square tests and Yates’ correction, with p values
< 0.05 being regarded as significant.
RESULTS
CSF was collected from 79 children (aged
2–13 years) and 20 adults (aged 18–71 years) with
acute neurological illness for whom virus aseptic
meningitis ⁄ encephalitis was suspected. Quantita-
tive and qualitative cytological examinations of
CSF revealed white cell counts (WCCs) of
5–1210 ⁄mm3,with apredominance of lymphocytes
(n = 87), normal glucose values, andprotein values
of 15–217 mg ⁄dL. The percentages of lymphocytes
and neutrophils were, respectively, 7–100% (med-
ian 68%) and 2–90% (median 34%). The results of
bacteriological and fungal investigations were
negative in all cases. The duration of hospitalisa-
tion was short (3–9 days; mean 6.3 days).
Table 2 summarises the results obtained with
virus culture and the Enterovirus Consensus kit.
Of the 99 patients, samples from 65 (65.5%) were
negative by both RT-PCR and culture, while
samples from 18 patients were positive by both
techniques. There was an 83.8% correlation
between the two assays.
Samples from 33 (33.3%) patients were positive
by RT-PCR and 19 (19.1%) by culture. Sixteen
discrepant results were obtained: RT-PCR was
positive for 15 culture-negative specimens, while
one culture-positive specimen was negative by
RT-PCR. Very few enterovirus cultures were
performed from throat or rectal samples, so it
was not possible to use culture results from these
sites to resolve discrepancies between CSF cul-
tures and RT-PCR. However, according to the
criteria listed above to resolve discrepancies, the
sensitivity, specificity and positive and negative
predictive values for the Enterovirus Consensus
kit were 97%, 100%, 100% and 98.5%, respect-
ively. The corresponding figures for virus culture
were 57.5%, 100%, 100% and 82.5%, respectively.
The Enterovirus Consensus kit detected signifi-
cantly more patients (p < 0.01) with enterovirus
meningitis ⁄ encephalitis than did culture.
Of the 33 patients who yielded RT-PCR-
positive samples, 31 were children aged 2–
12 years (median 7 years). On admission, the
clinical symptoms of these children were: fever
(87.1%); vomiting (64.5%); headache (58%);
Table 1. European Union Concerted Action Enterovirus
Proficiency Panel
Code
Enterovirus
serotype Dilutiona Virus titreb
Expected
results
EV-C01 COX A9 10)8 0.036 Negative
EV-C02 COX A9 10)7 0.36 Positive
EV-C03 COX A9 10)6 3.6 Positive
EV-C04 No virus Negative
EV-C05 ECHO 6 10)4 20 000 Positive
EV-C06 ECHO 11 10)6 25.2 Positive
EV-C07 COX A5 10)5 317 Positive
EV-C08 ENTERO 71 10)5 56.4 Positive
EV-C09 ECHO 11 10)3 25 200 Positive
EV-C10 No virus Negative
EV-C11 ECHO 11 10)5 252 Positive
EV-C12 Control RNA 104c Positive
EV-C13 Control RNA 107c Positive
aDilution of original stock.
bTitre of original virus stock before inactivation and freeze–drying (TCID50 ⁄mL:
echovirus 6, 2.0 · 108; echovirus 11, 2.5 · 107; enterovirus 71, 5.6 · 106; coxsackie-
virus A9, 3.6 · 106; coxsackievirus B5, 3.2 · 107).
cRNA copies/mL.
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nuchal rigidity (35.5%); anorexia (22.6%); abdom-
inal pain (12.9%); photophobia (12.9%); cough
(9.7%); malaise (9.7%); drowsiness (6.4%); rash
(6.4%); and nausea, otitis, rhinitis, pharyngitis
and movement disorders (3.2% each). WCCs
were in the range 15–1202 ⁄mm2 (median
62 ⁄mm3), with a predominance of lymphocytes
in 25 CSFs. Six CSFs had a relative percentage
of neutrophils of 60–90%, with WCCs of 20–
1202 ⁄mm3. CSF protein values were normal in 24
specimens. Sixteen of 31 specimens were culture-
positive, with WCCs of 20–1202 ⁄mm3.
CSF from one child contained RT-PCR inhibi-
tors (inhibition control result < 0.8 optical density
units and specimen result negative with the
enterovirus probe control), but yielded a positive
culture result. This patient (a female aged 6 years)
had signs and symptoms consistent with aseptic
meningitis (fever, headache and malaise), but had
a WCC of only 12 cells ⁄mm3, with a predomin-
ance (85%) of lymphocytes. The original CSF
specimen was re-extracted and retested, and was
again negative by RT-PCR. This result was there-
fore classified as a false-negative.
Two patients from the adult group yielded
positive RT-PCR samples: one patient, aged
71 years with a clinical history of diabetes mell-
itus, was admitted with fever, drowsiness and
nuchal rigidity; the second, aged 18 years, was
admitted with fever, nuchal rigidity and photo-
phobia. CSF parameters were normal for the first
patient (WCC of 5 ⁄mm3), while CSF from the
second patient had a WCC of 380 ⁄mm3 (90%
lymphocytes) and normal protein and glucose
levels. These two patients also yielded entero-
virus-positive samples.
Of the 65 patients who yielded RT-PCR- and
culture-negative samples, 47 were children and 18
were adults. On admission, these patients had
signs and symptoms of meningeal inflammation
with, in addition to headache, fever and nuchal
rigidity, neurological manifestations that inclu-
ded irritability (13.8%), alterations of conscious-
ness (7.7%) and seizures (6%). The WCCs were
5–1210 ⁄mm2 (median 96 ⁄mm3), with a predom-
inance of lymphocytes and mononuclear cells in
59 CSFs. Six CSFs had 75–90% neutrophils, and
WCCs of 40–980 ⁄mm3. CSF protein values were
normal for 52 specimens.
When samples from the Third QCCA Entero-
virus proficiency panel were tested by RT-PCR,
the results obtained were as expected. For cox-
sackievirus A9, 1 TCID50 (vial 3) and 0.1 TCID50
(vial 2) were detected, but 0.01 TCID50 (vial 1) was
not detected. Both samples containing coxsackie-
virus B5 (100 TCID50; vial 7), as well as the only
sample containing echovirus 6 (10000 TCID50; vial
5), were positive. For echovirus 11, the samples
containing 10 000 TCID50 (vial 9), 100 TCID50 (vial
11) and 10 TCID50 (vial 6) were positive. The only
sample containing enterovirus 71 (10 TCID50; vial
8) was also positive (Table 1).
DISCUSSION
The 99 patients in this prospective study formed a
homogeneous group with symptoms of menin-
gitis ⁄ encephalitis and an absence of detectable
bacterial pathogens in CSF. The RT-PCR method
detected all enterovirus serotypes, except echovi-
ruses 22 and 23, which are thought to be genetic-
ally distinct picornaviruses and have been
reclassified recently as parechoviruses 1 and 2,
and which are isolated rarely from CSF samples
[1,25–27].
The primers (Penter-1 and -2) used in the
Enterovirus Consensus kit form a ‘stair’ primer
system. The principle of stair primers is that a
classical pair of primers is replaced with a set of
equimolar oligonucleotides of variable length, in
which the 5¢-terminal sequences are unchanged
(with a constant length of amplified fragment),
but the 3¢ end is displaced base by base [28]. The
advantages of stair primers are their recognition
of all the known enterovirus serotypes [24,25] and
the efficient amplification that results in the
presence of mutations which affect the 3¢ extrem-
ity. This is important for quantitative PCR and the
Table 2. Comparison of the results of the Enterovirus Consensus RT-PCR kit with virus culture for 99 cerebrospinal fluid
specimens
Method
Specimen numbers
Sensitivity (%) Specificity (%)
Predictive value
True-positive True-negative False-positive False-negative Positive (%) Negative (%)
PCR 33 65 0 1 97.0 100.0 100.0 98.5
Culture 19 66 0 14 57.5 100.0 100.0 82.5
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avoidance of non-specific priming [28]. Detection
of the amplified product with a specific 5¢-biotin-
ylated probe is not entirely specific, because of
cross-reaction with rhinovirus 3 [25,29]. This was
not a problem in the present study, since rhino-
virus is found only in respiratory samples, and 60
clinical specimens analysed in parallel with the
Enterovirus Consensus kit and PCR techniques
described by Zoll et al. [15] and Rotbart et al. [18]
yielded similar results, with a sensitivity for the
Enterovirus Consensus kit that was equivalent to
that obtained by other techniques described pre-
viously for clinical samples [24,25]. Moreover,
Penter primers amplified all 64 serotypes of
enteroviruses, including both prototype and field
strains [25], while the primers described by Zoll
et al. [15] did not recognise coxsackieviruses A11,
A17 and A24 and echovirus 16, and the Rotbart
primers did not always recognise echoviruses 1
and 5 [30].
A specific virological diagnosis of enterovirus
meningitis depends on isolation of the virus from
CSF in tissue culture, although the sensitivity for
enterovirus serotypes is only 65–75%, mainly
because of the inability of certain serotypes
(coxsackie A viruses) to grow in cell culture
[2,31] and the low titres of enterovirus in CSF [32].
In the present study, shell vial culture was used as
an alternative to conventional virus isolation. This
assay has the important features of being more
rapid, sensitive and specific [33]. The sensitivity
of shell vial culture was 57.5%, similar to that
reported by Taggart et al. [34] (50%) and Carroll
et al. [16] (55.8%), and to the sensitivity of
conventional cell culture [19–21,35].
Many of the drawbacks related to culture are
overcome by amplification assays. The commer-
cial RT-PCR assay evaluated in the present study
had a sensitivity compared to culture of 97%,
which was in accordance with the sensitivity of
other similar methods [18,19,36], and a specificity
of 100%, which was slightly better than reported
previously [18–20]. These figures were also sim-
ilar to those reported for different amplification
methods, such as the Roche Amplicor EV test [16],
a real-time RT-PCR assay [21,35] and nucleic acid
sequence-based amplification methodology
[17,37]. As reported previously [16,30,36,38], there
was a statistically significant improvement in the
detection of enterovirus central nervous system
disease with PCR compared to culture, and a very
good correlation (80–85.9%) between the two
assays [16,34]. Recently, Buck et al. [39] compared
a newly described shell vial assay, in which a
mixture of human colon carcinoma and genetic-
ally engineered buffalo green monkey kidney
cells (Super E-mix) was used, with two commer-
cially available RT-PCR assays (one of which was
the Enterovirus Consensus kit) and conventional
cell culture for the diagnosis of enterovirus
meningitis. Even though the Super E-Mix proce-
dure had a greater sensitivity than conventional
cell culture (i.e., 76% vs. 51%), the Enterovirus
Consensus kit appeared to offer more sensitive
detection of enterovirus in CSF [39]. Inclusion of
the two dilution series of coxsackievirus A9 and
echovirus 11 from the EU-QCCA Proficiency
Panel provided an opportunity in the present
study to evaluate the detection limit of the assay,
which was found to be similar to that obtained
with a real-time fluorescence PCR assay [40].
Diagnosis of aseptic meningitis with RT-PCR
requires not only a sensitive method, but also a
technique that can monitor problems associated
with PCR inhibitors [16,21,41]. Although the exact
nature of inhibition is unknown [16,21], it could
be explained by the presence of a high level of
RNase activity or by Taq DNA polymerase inhib-
itors that were co-purified with RNA [36]. The
Enterovirus Consensus kit contains a plasmid
control that allows the detection of amplification
inhibitors in the specimen. Another advantage of
the kit was that the method was relatively easy to
perform, with the entire assay completed in < 8 h,
compared to 48–72 h for shell vials. It has been
suggested [42] that PCR assays for enterovirus
detection should be introduced as routine tests, as
an early positive PCR result could conserve
considerable healthcare resources [6,16,43]. The
format of the kit is such that the reagents can be
used in a flexible way, so that laboratories in
which small numbers of samples are tested on a
regular basis can make use of the methodology.
The clinical diagnosis of aseptic meningitis
depends on routine examination of CSF [44],
and it is therefore appropriate to evaluate the
RT-PCR assay against an observation of pleocy-
tosis without any other cause [2]. In previous
reports describing PCR assays, the proportion of
meningitis cases without pleocytosis was low
(3.2–7%) [38,45]. Moreover, in some studies, the
absence of pleocytosis could be used to discour-
age RT-PCR testing of all patients [45], or of older
children (aged > 2 years) and adults [19]. The
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present study examined only five CSF specimens
without pleocytosis (WCC £ 5 ⁄mm3), and one
was positive. Consequently, it seems that cytolo-
gical examination of CSF may not be of great
value in ruling out virus meningitis or in deciding
whether to perform RT-PCR for enteroviruses.
Indeed, irrespective of patient age and cytological
results, RT-PCR assay may be of value in all cases
of suspected enterovirus meningitis [42].
Among the patients with negative RT-PCR
results, clinical manifestations and CSF analysis
indicated that they suffered from a virus central
nervous system infection. The results were suffi-
cient to rule out enterovirus infection, but specific
tests (i.e., culture and PCR) for other neurotropic
viruses were not performed. However, epidemio-
logical studies have indicated that a specific virus
pathogen is identified in 60% of aseptic meningitis
patients when consistent conventional diagnostic
methodologies are used, compared with 80–85%
of cases if conventional laboratory methods and
enterovirus PCR are combined [2,31].
In conclusion, the Enterovirus Consensus
RT-PCR kit demonstrated superior sensitivity
and speed compared with virus culture, excellent
specificity and positive predictive value (100%
each), a clear delineation of positive samples,
minimal amplification inhibition, and a high neg-
ative predictive value (98.5%). Importantly, the kit
recognised all known serotypes of enteroviruses,
and provided an inhibition control to monitor the
amplification efficiency. The kit was suitable for
use in the routine diagnostic laboratory, and the
implementation of such methodology would have
a considerable impact on patient care by reducing
the duration of hospitalisation, inappropriate use
of antibiotic therapy, and unnecessary investiga-
tions.
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